Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Concert Pharmaceuticals, Inc. (CNCE)

« Back to company index

CNCE Chatter Timeline

Stock Ticker for CNCE

Most Active Tweeters for CNCE

UserTweets
@PennySearch 5
@Tickeron 2
@InsiderForms 1
@newsfilterio 1
@StckPro 1

Recent Tweets for CNCE

Tickeron @Tickeron
$CNCE's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/qluoLkelTa
January 24th 2022, 3:01am
PennySearch @PennySearch
$CNCE Mizuho gave CNCE a Buy stock rating on 2021-10-05. Find top penny stocks with PennySearch before the moon… https://t.co/BZau5FyKP3
January 22nd 2022, 8:01pm
PennySearch @PennySearch
$CNCE Mizuho gave CNCE a Buy stock rating on 2021-10-05. Find top penny stocks with PennySearch before the moon… https://t.co/M7JmAeVrMG
January 21st 2022, 7:01pm
PennySearch @PennySearch
$CNCE Mizuho gave CNCE a Buy stock rating on 2021-10-05. Find top penny stocks with PennySearch before the moon… https://t.co/YZuOgqYXiA
January 20th 2022, 8:01pm
StckPro @StckPro
$CNCE NEW ARTICLE : Berenberg Bank Thinks Concert Pharma’s Stock is Going to Recover https://t.co/LdTg49DsXQ Get al… https://t.co/PmgWEvk5cO
January 20th 2022, 3:01am
PennySearch @PennySearch
$CNCE Mizuho gave CNCE a Buy stock rating on 2021-10-05. Find top penny stocks with PennySearch before the moon… https://t.co/tQUP9AlCdg
January 19th 2022, 7:01am
Tickeron @Tickeron
$CNCE's 10-day Moving Average moved below its 50-day Moving Average on December 28, 2021. View odds for this and ot… https://t.co/q4ZRJmqZOE
January 17th 2022, 8:01pm
newsfilterio @newsfilterio
Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $CNCE https://t.co/2c61sBGf8k
January 14th 2022, 7:01am
PennySearch @PennySearch
$CNCE Mizuho gave CNCE a Buy stock rating on 2021-10-05. Find top penny stocks with PennySearch before the moon… https://t.co/47kKN9GpTu
January 13th 2022, 11:01pm
InsiderForms @InsiderForms
$CNCE BANK OF America CORP /DE/ has filed Form SC 13G/A with SEC. Reporting 2.9% Ownership. Try Insider Forms mobi… https://t.co/rvxfws6QvG
January 13th 2022, 3:01pm
FlashAlert_me @FlashAlert_me
$CNCE [15s. delayed] filed form SC 13G/A on January 13, 10:20:48 https://t.co/iIO5R1Ysh8
January 13th 2022, 3:01pm
mediasentiment @mediasentiment
$CNCE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 814
January 12th 2022, 1:01am
InsiderAlerts4U @InsiderAlerts4U
$CNCE: New Insider Filing on CONCERT PHARMACEUTICALS, INC.'s Chief Operating Officer NANCY STUART: https://t.co/obLfLJ0I8y
January 11th 2022, 12:01pm
PennySearch @PennySearch
$CNCE Mizuho gave CNCE a Buy stock rating on 2021-10-05. Find top penny stocks with PennySearch before the moon… https://t.co/xyhWqBu0Xv
January 10th 2022, 9:01pm
NancStu @NancStu
RT @ConcertPharma: $CNCE will be presenting at the #HCWBioConnect Conference today. Listen to the on-demand presentation here: https://t.co…
January 10th 2022, 1:01pm
ConcertPharma @ConcertPharma
$CNCE will be presenting at the #HCWBioConnect Conference today. Listen to the on-demand presentation here:… https://t.co/0Mg7G5xegE
January 10th 2022, 12:01pm
InsiderAlerts4U @InsiderAlerts4U
$CNCE: New Insider Filing on CONCERT PHARMACEUTICALS, INC.'s Chief Development Officer JAMES V CASSELLA: https://t.co/UxSInsxcbe
January 10th 2022, 3:01am
InsiderAlerts4U @InsiderAlerts4U
$CNCE: New Insider Filing on CONCERT PHARMACEUTICALS, INC.'s Chief Financial Officer MARC A. BECKER: https://t.co/RijCxbIadH
January 9th 2022, 3:01pm
Tickeron @Tickeron
$CNCE's price moved below its 50-day Moving Average on December 22, 2021. View odds for this and other indicators:… https://t.co/SmwKiiBwzt
January 8th 2022, 3:01pm
InsiderAlerts4U @InsiderAlerts4U
$CNCE: New Insider Filing on CONCERT PHARMACEUTICALS, INC.'s Chief Legal Officer JEFFREY A MUNSIE: https://t.co/kTKIkboqT6
January 8th 2022, 11:01am
InsiderAlerts4U @InsiderAlerts4U
$CNCE: New Insider Filing on CONCERT PHARMACEUTICALS, INC.'s Chief Executive Officer ROGER D TUNG: https://t.co/us5Ohg8YHM
January 8th 2022, 1:01am
aistockfinder @aistockfinder
$CNCE https://t.co/xBtFdtJNtb Concert Pharmaceuticals Inc. Our model is predicting this company s stock price has a… https://t.co/tcrPfq3LTA
January 7th 2022, 11:01pm
InsiderForms @InsiderForms
$CNCE Insider Becker Marc A. has Sold 2,894 Shares. Title :Chief Financial Officer Total Cost: $9,260.8 Buy/Sell :… https://t.co/q6gMeLpSyH
January 7th 2022, 9:01pm
FlashAlert_me @FlashAlert_me
$CNCE [15s. delayed] filed SEC form 4: Chief Operating Officer Stuart Nancy: Disposed 2,894 of Common Stock at pri… https://t.co/r9Z3j4QNI9
January 7th 2022, 9:01pm
FlashAlert_me @FlashAlert_me
$CNCE [15s. delayed] filed SEC form 4: Chief Executive Officer Tung Roger D: Disposed 23,740 of Common Stock at av… https://t.co/3l3S6VSh2X
January 7th 2022, 9:01pm
formwhisperscom @formwhisperscom
#FWSells $CNCE Tung Roger D, Chief Executive Officer of CONCERT PHARMACEUTICALS, INC. sold 9,240 shares on 2022-01-… https://t.co/PFmSA9UxP0
January 7th 2022, 9:01pm
formwhisperscom @formwhisperscom
#FWSells $CNCE Munsie Jeffrey A, Chief Legal Officer of CONCERT PHARMACEUTICALS, INC. sold 2,894 shares on 2022-01-… https://t.co/FQ2CYla841
January 7th 2022, 9:01pm
formwhisperscom @formwhisperscom
#FWSells $CNCE Stuart Nancy, Chief Operating Officer of CONCERT PHARMACEUTICALS, INC. sold 2,894 shares on 2022-01-… https://t.co/G43Q7zDpEK
January 7th 2022, 9:01pm
FlashAlert_me @FlashAlert_me
$CNCE [15s. delayed] filed SEC form 4: Chief Legal Officer Munsie Jeffrey A: Disposed 2,894 of Common Stock at pri… https://t.co/YDFHflBaEE
January 7th 2022, 9:01pm
FlashAlert_me @FlashAlert_me
$CNCE [15s. delayed] filed SEC form 4: Chief Development Officer Cassella James V: Disposed 2,894 of Common Stock… https://t.co/WteHhxGP4r
January 7th 2022, 9:01pm
formwhisperscom @formwhisperscom
#FWSells $CNCE Becker Marc A., Chief Financial Officer of CONCERT PHARMACEUTICALS, INC. sold 2,894 shares on 2022-0… https://t.co/R7wYw6lxTR
January 7th 2022, 9:01pm
formwhisperscom @formwhisperscom
#FWSells $CNCE Cassella James V, Chief Development Officer of CONCERT PHARMACEUTICALS, INC. sold 2,894 shares on 20… https://t.co/ei5JfLDM8L
January 7th 2022, 9:01pm
FlashAlert_me @FlashAlert_me
$CNCE [15s. delayed] filed SEC form 4: Chief Financial Officer Becker Marc A.: Disposed 2,894 of Common Stock at p… https://t.co/x0jJq18PcJ
January 7th 2022, 9:01pm
PennySearch @PennySearch
$CNCE Mizuho gave CNCE a Buy stock rating on 2021-10-05. Find top penny stocks with PennySearch before the moon… https://t.co/SR4thBjeiZ
January 6th 2022, 1:01am
PennySearch @PennySearch
$CNCE Mizuho gave CNCE a Buy stock rating on 2021-10-05. Find top penny stocks with PennySearch before the moon… https://t.co/OuybRiTL1y
January 5th 2022, 5:01pm
khmerxbxboi @khmerxbxboi
Retweet if you bullish on $CNCE this year 2022 ! https://t.co/vnD1rLCo2U
January 5th 2022, 2:01pm
mediasentiment @mediasentiment
$CNCE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 423
January 5th 2022, 3:01am
coreinv1 @coreinv1
RT @JD4for4: Concert Pharmaceuticals completes enrollment in phase 3 study of hair loss disorder drug. $CNCE CTP-543 has NICE 5-yr exclusiv…
January 4th 2022, 7:01pm
MarcJacksonLA @MarcJacksonLA
$CNCE Concert Pharmaceuticals Completes Enrollment in THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alop… https://t.co/spC7Si0saV
January 4th 2022, 4:01pm
Tickeron @Tickeron
$CNCE's price moved below its 50-day Moving Average on December 22, 2021. View odds for this and other indicators:… https://t.co/tOfPCLvA12
January 4th 2022, 3:01pm
JD4for4 @JD4for4
Concert Pharmaceuticals completes enrollment in phase 3 study of hair loss disorder drug. $CNCE CTP-543 has NICE 5-… https://t.co/uMxHvCptZp
January 4th 2022, 2:01pm
StckPro @StckPro
$CNCE NEW ARTICLE : Concert Pharmaceuticals completes enrollment in phase 3 study of hair loss disorder drug… https://t.co/pSPV33Nx9A
January 4th 2022, 1:01pm
MarketCurrents @MarketCurrents
$CNCE - Concert Pharmaceuticals completes enrollment in phase 3 study of hair loss disorder drug https://t.co/b6wwTvSEIv
January 4th 2022, 1:01pm
GeorgeB14941177 @GeorgeB14941177
$CNCE Concert Pharmaceuticals Completes Enrollment in THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for… https://t.co/7ZEv2ORg8i
January 4th 2022, 1:01pm
equity_newswire @equity_newswire
$CNCE Concert Pharmaceuticals Completes Enrollment in THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alop… https://t.co/qQ4tXEhadv
January 4th 2022, 1:01pm
gcassidy718 @gcassidy718
$CNCE Concert Pharmaceuticals Completes Enrollment in THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alop… https://t.co/mEAeNoyBRp
January 4th 2022, 1:01pm
MaisaCorp @MaisaCorp
$CNCE Enrollment in the first phase 3 trial was completed in October, with topline data expected in Q2 of 2022. Top… https://t.co/jAvl8fMubw
January 4th 2022, 1:01pm
MaisaCorp @MaisaCorp
$CNCE has completed patient enrollment in the second phase 3 clinical trial to evaluate the efficacy and safety of… https://t.co/Cd1Ec0YD8R
January 4th 2022, 1:01pm
Tickeron @Tickeron
If you’re trading this week, Read This! $CNCE RSI Indicator left the oversold zone. #ConcertPharmaceuticals… https://t.co/7KMOS3XZaZ
January 4th 2022, 12:01pm
FlashAlert_me @FlashAlert_me
$CNCE [15s. delayed]: Issued Press Release on January 04, 07:00:00: Concert Pharmaceuticals Completes Enrollment in… https://t.co/VzWGPidsOC
January 4th 2022, 12:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.